Fora Capital, LLC Seres Therapeutics, Inc. Transaction History

Fora Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $21,485 - $88,931	-3,935 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $72,640 - $95,856	3,935 New	3,935 $94 Million
Q4 2020 Feb 12, 2021	SELL	$23.25 - $37.73 $54,660 - $88,703	-2,351 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.74 - $28.74 $8,792 - $67,567	2,351 New	2,351 $67 Million

41M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $103M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.